Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy: An Open, Prospective, Multicenter, Randomized Phase III Study

NCT00242606 is registered in ClinicalTrials.gov with Philipps University Marburg as lead sponsor.

NCT NCT00242606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00242606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy: An Open, Prospective, Multicenter, Randomized Phase III Study
Lead sponsor
Philipps University Marburg
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2005
Completion date
January 31, 2009
Enrollment
409 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy